Attovia Therapeutics ATTO
$15.10 −$0.48 (-3.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.10 0.00%
Open$15.40
Prev close$15.58
Day range$14.80 – $15.46
Volume372.2K
Market cap$690.26M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts4
Average target$41.00+171.5% vs. price
- Buy 100%
Low $34.00Now $15.10Avg $41.00High $45.00
Recent rating changes
The last 13 actions on file set price targets from $30.00 to $45.00, averaging $39.38.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | Morgan Stanley | BUY | $40.00 |
| 10 Nov 2026 | Citi | BUY | $34.00 |
| 9 Nov 2026 | RBC Capital | BUY | $45.00 |
| 13 Oct 2026 | Citi | BUY | $30.00 |
| 5 Sep 2026 | LifeSci Capital | BUY | $45.00 |
| 3 Sep 2026 | LifeSci Capital | BUY | $45.00 |
| 3 Sep 2026 | Morgan Stanley | BUY | $39.00 |
| 3 Sep 2026 | Citi | BUY | $30.00 |
| 2 Sep 2026 | RBC Capital | BUY | $45.00 |
| 31 Aug 2026 | LifeSci Capital | BUY | $45.00 |
| 31 Aug 2026 | Morgan Stanley | BUY | $39.00 |
| 31 Aug 2026 | Citi | BUY | $30.00 |
| 30 Aug 2026 | RBC Capital | BUY | $45.00 |
No comments yet — be the first to weigh in on ATTO.
Sign in to join the discussion.